文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Fecal Microbiota in Patients with Irritable Bowel Syndrome Compared with Healthy Controls Using Real-Time Polymerase Chain Reaction: An Evidence of Dysbiosis.

作者信息

Shukla Ratnakar, Ghoshal Ujjala, Dhole Tapan N, Ghoshal Uday C

机构信息

Department of Microbiology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, 226014, India.

Departments of Gastroenterology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, 226014, India.

出版信息

Dig Dis Sci. 2015 Oct;60(10):2953-62. doi: 10.1007/s10620-015-3607-y. Epub 2015 Mar 18.


DOI:10.1007/s10620-015-3607-y
PMID:25784074
Abstract

BACKGROUND: Dysbiosis may play a role in irritable bowel syndrome (IBS), hitherto an enigmatic disorder. We evaluated selected fecal microbes in IBS patients and healthy controls (HC). METHODS: Fecal 16S rRNA copy number of selected bacteria was studied using qPCR in 47 patients with IBS (Rome III) and 30 HC. RESULTS: Of 47 patients, 20 had constipation (IBS-C), 20 diarrhea (IBS-D), and seven unclassified IBS (IBS-U). Relative difference in 16S rRNA copy number of Bifidobacterium (P = 0.042) was lower, while those of Ruminococcus productus-Clostridium coccoides (P = 0.016), Veillonella (P = 0.008), Bacteroides thetaiotamicron (P < 0.001), Pseudomonas aeruginosa (P < 0.001), and Gram-negative bacteria (GNB, P = 0.001) were higher among IBS patients than HC. Number of Lactobacillus (P = 0.002) was lower, while that of Bacteroides thetaiotamicron (P < 0.001) and segmented filamentous bacteria (SFB, P < 0.001) was higher among IBS-D than IBS-C. Numbers of Bacteroides thetaiotamicron (P < 0.001), P. aeruginosa (P < 0.001), and GNB (P < 0.01) were higher among IBS-C and IBS-D than HC. Quantity of SFB was higher among IBS-D (P = 0.011) and lower among IBS-C (P = 0.002) than HC. Number of Veillonella species was higher among IBS-C than HC (P = 0.002). P. aeruginosa was frequently detected among IBS than HC (46/47 [97.9 %] vs. 10/30 [33.3 %], P < 0.001). Abdominal distension (n = 34/47) was associated with higher number of Bacteroides thetaiotamicron, Clostridium coccoides, P. aeruginosa, SFB, and GNB; bloating (n = 22/47) was associated with Clostridium coccoides and GNB. Microbial flora was different among IBS than HC on principal component analysis. CONCLUSION: Fecal microbiota was different among IBS than HC, and different sub-types were associated with different microbiota. P. aeruginosa was more frequent and higher in number among IBS patients.

摘要

相似文献

[1]
Fecal Microbiota in Patients with Irritable Bowel Syndrome Compared with Healthy Controls Using Real-Time Polymerase Chain Reaction: An Evidence of Dysbiosis.

Dig Dis Sci. 2015-10

[2]
Analysis of the fecal microbiota of irritable bowel syndrome patients and healthy controls with real-time PCR.

Am J Gastroenterol. 2005-2

[3]
Identification of an Intestinal Microbiota Signature Associated With Severity of Irritable Bowel Syndrome.

Gastroenterology. 2016-10-7

[4]
Fecal and Mucosa-Associated Intestinal Microbiota in Patients with Diarrhea-Predominant Irritable Bowel Syndrome.

Dig Dis Sci. 2018-5-17

[5]
Gut fungal dysbiosis and altered bacterial-fungal interaction in patients with diarrhea-predominant irritable bowel syndrome: An explorative study.

Neurogastroenterol Motil. 2020-11

[6]
Increase in fecal primary bile acids and dysbiosis in patients with diarrhea-predominant irritable bowel syndrome.

Neurogastroenterol Motil. 2012-2-22

[7]
Gut Microbial Dysbiosis in the Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of Case-Control Studies.

J Acad Nutr Diet. 2019-8-28

[8]
Diarrhoea-predominant irritable bowel syndrome distinguishable by 16S rRNA gene phylotype quantification.

World J Gastroenterol. 2009-12-21

[9]
Characteristic dysbiosis of gut microbiota of Chinese patients with diarrhea-predominant irritable bowel syndrome by an insight into the pan-microbiome.

Chin Med J (Engl). 2019-4-20

[10]
Fecal bacteria can predict the efficacy of rifaximin in patients with diarrhea-predominant irritable bowel syndrome.

Pharmacol Res. 2020-9

引用本文的文献

[1]
The Interplay Between Immunological Status and Gut Microbial Dysbiosis in the Development of the Symptoms of Irritable Bowel Syndrome: A Systematic Review with Meta-Analysis.

Dig Dis Sci. 2025-9-3

[2]
Microbiome impacts quality of life in patients with endometrial cancer and benign gynecological conditions.

Qual Life Res. 2025-7-19

[3]
Fecal microbiota transplantation: application scenarios, efficacy prediction, and factors impacting donor-recipient interplay.

Front Microbiol. 2025-3-25

[4]
Periodic Changes in the Gut Microbiome in Women with the Mixed Type of Irritable Bowel Syndrome.

Biomedicines. 2025-3-7

[5]
Gut Microecological Prescription: A Novel Approach to Regulating Intestinal Micro-Ecological Balance.

Int J Gen Med. 2025-2-5

[6]
Consumption of resistant potato starch produces changes in gut microbiota that correlate with improvements in abnormal bowel symptoms: a secondary analysis of a clinical trial.

BMC Nutr. 2024-11-27

[7]
Gut microbiota and irritable bowel syndrome: status and prospect.

Front Med (Lausanne). 2024-10-17

[8]
Crisis in the gut: navigating gastrointestinal challenges in Gulf War Illness with bioengineering.

Mil Med Res. 2024-7-8

[9]
From the Gut to the Brain: Is Microbiota a New Paradigm in Parkinson's Disease Treatment?

Cells. 2024-4-30

[10]
and irritable bowel syndrome.

Trop Parasitol. 2024

本文引用的文献

[1]
Development, Translation and Validation of Enhanced Asian Rome III Questionnaires for Diagnosis of Functional Bowel Diseases in Major Asian Languages: A Rome Foundation-Asian Neurogastroenterology and Motility Association Working Team Report.

J Neurogastroenterol Motil. 2015-1-1

[2]
Alterations of the gut microbiome and metabolome in alcoholic liver disease.

World J Gastrointest Pathophysiol. 2014-11-15

[3]
Associations between IL-1RA polymorphisms and small intestinal bacterial overgrowth among patients with irritable bowel syndrome from India.

Neurogastroenterol Motil. 2014-10

[4]
Interactions between Bifidobacterium and Bacteroides species in cofermentations are affected by carbon sources, including exopolysaccharides produced by bifidobacteria.

Appl Environ Microbiol. 2013-9-27

[5]
Effect of multispecies probiotics on irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial.

J Gastroenterol Hepatol. 2014-1

[6]
Effect of probiotic bacteria on the intestinal microbiota in irritable bowel syndrome.

J Gastroenterol Hepatol. 2013-10

[7]
Effect of repeated Campylobacter jejuni infection on gut flora and mucosal defense in a rat model of post infectious functional and microbial bowel changes.

Neurogastroenterol Motil. 2013-3-22

[8]
Role of commensal gut bacteria in inflammatory bowel diseases.

Gut Microbes. 2012-10-11

[9]
The microbiota link to irritable bowel syndrome: an emerging story.

Gut Microbes. 2012-8-16

[10]
The gut microbiota and irritable bowel syndrome: friend or foe?

Int J Inflam. 2012

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索